Loading
CQ
Changzhou Qianhong Biopharma Co.,Ltd Stock: price and insider trades · China
千红制药
No insider purchase over the last 90 days. The latest, by 王轲, was filed 30 Jun 2022.
Changzhou Qianhong Biopharma Co.,Ltd: what insiders have been doing
Changzhou Qianhong Biopharma Co.,Ltd, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). Changzhou Qianhong Biopharma Co.,Ltd has had no insider filing for more than a year; the last one goes back to 29 May 2025.
Over the whole record (from 2022), the tally stands at 2 purchases and 4 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Insider Decl.
6
Thresholds
n/a
Buy Volume
€10M
2 ops. · all time
Sell Volume
€5M
4 ops. · all time
Who traded when
BuySale赵刚1 sale
Since the insiders bought
- -9.6%Entry CN¥5.75 · Close at T+365 CN¥5.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 5,491 of 26,316 companies
66.5
score / 100
Value50
Quality83
FCF yld2.8%
Earn yld5.0%
EV/EBITDA15.4x
ROE10.0%
Gross mgn58%
Net mgn25%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥6.59
Analyst consensus
Income statement
RevenueCN¥1.6B
Gross profitCN¥916.9M58% margin
EBITDACN¥516.5M33% margin
Net incomeCN¥398.8M20.0% margin
Valuation
PER (trailing)28.7x
P/Book3.0x
Beta0.02
Balance sheet & cash
Market capCN¥8.4B
Total debtCN¥3.1M
Free Cash FlowCN¥219.8M
Debt / Equity1%
Profitability & ownership
ROE10.0%
ROA5.4%
% insiders41.6%
% institutions2.0%
Last declaration on 29 May 2025
Declarations6 total
4,739,600 shares100.0% of flowA股XSHESZSE:173000008997137920
4,200,000 shares28.8% of flowA股XSHESZSE:173000005758300000
Canonical exit: 28 Sept 2022 (T+90)
10,000,000 shares71.2% of flowA股XSHESZSE:173000005635481860
Canonical exit: 27 Sept 2022 (T+90)
599,900 shares100.0% of flowA股XSHESZSE:173000005513604800
240,000 shares100.0% of flowA股XSHESZSE:173000005536519700
75,000 shares100.0% of flowA股XSHESZSE:173000005365213500
6 of 6 declarations
About Changzhou Qianhong Biopharma Co.,Ltd
千红制药 is a company specializing in the health and pharmaceutical sector, offering a range of pharmaceutical products. It is listed on the XSHE market.
